Want to see IN:TAKE full AI Analyst Report?
TAKE Stock Chart & Stats
₹20.76
₹0.05(0.24%)
At close: 4:00 PM EDT
₹20.76
₹0.05(0.24%)
Day’s Range― - ―
52-Week Range₹9.85 - ₹49.90
Previous CloseN/A
Volume250.59K
Average Volume (3M)58.94K
Market Cap
₹2.41B
Enterprise Value₹1.67K
Total Cash (Recent Filing)₹2.80M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)18.6
Beta1.32
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.87
Shares Outstanding147,934,000
10 Day Avg. Volume129,011
30 Day Avg. Volume58,943
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)18.74
Price to Sales (P/S)10.72
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Zero Reported DebtThe absence of reported debt reduces interest burden and refinancing exposure, giving TAKE greater financial flexibility while it works to stabilize operations and improve profitability.
Positive Equity RestoredRestored positive equity improves balance-sheet resilience compared with the FY2024 impairment. This provides a stronger capital base for maintaining operations and addressing business volatility.
Life-sciences Sector SpecializationA focused life-sciences model aligns the company with regulated workflows such as clinical, regulatory, quality and supply-chain operations. Domain specialization can support repeat demand where clients require validated expertise.
Bears Say
Negative Operating Cash FlowPersistent negative operating cash flow indicates weak earnings conversion and can constrain funding for delivery, investment and working capital. The divergence from reported profit raises concerns about the durability of cash generation.
Weak Core ProfitabilityNegative gross and operating profit show that the core business was not economically profitable in FY2026. Positive net income appears influenced by below-the-line items, making reported earnings less reliable as an indicator of operating strength.
Highly Volatile Revenue And EarningsExtreme revenue swings and a steep EPS decline indicate an unstable earnings base and limited visibility. Such volatility can weaken customer and employee confidence while making sustained margin improvement harder to assess.
TAKE Solutions Limited News
TAKE FAQ
What was TAKE Solutions Limited’s price range in the past 12 months?
TAKE Solutions Limited lowest stock price was ₹9.85 and its highest was ₹49.90 in the past 12 months.
What is TAKE Solutions Limited’s market cap?
TAKE Solutions Limited’s market cap is ₹2.41B.
When is TAKE Solutions Limited’s upcoming earnings report date?
TAKE Solutions Limited’s upcoming earnings report date is Nov 05, 2026 which is in 66 days.
How were TAKE Solutions Limited’s earnings last quarter?
TAKE Solutions Limited released its earnings results on Aug 11, 2026. The company reported ₹0.072 earnings per share for the quarter.
Is TAKE Solutions Limited overvalued?
According to Wall Street analysts TAKE Solutions Limited’s price is currently Overvalued.
Does TAKE Solutions Limited pay dividends?
TAKE Solutions Limited pays a Semiannually dividend of ₹0.4 which represents an annual dividend yield of N/A. See more information on TAKE Solutions Limited dividends here
What is TAKE Solutions Limited’s EPS estimate?
TAKE Solutions Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TAKE Solutions Limited have?
TAKE Solutions Limited has 147,934,000 shares outstanding.
What happened to TAKE Solutions Limited’s price movement after its last earnings report?
TAKE Solutions Limited reported an EPS of ₹0.072 in its last earnings report. Following the earnings report the stock price went up 1.174%.
Which hedge fund is a major shareholder of TAKE Solutions Limited?
Currently, no hedge funds are holding shares in IN:TAKE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TAKE Solutions Limited
TAKE Solutions Limited, operating across the United States, Asia Pacific, and Europe, specializes in providing expert services and cutting-edge solutions for the life sciences and supply chain management sectors. For the life sciences industry, the company delivers technology-driven and proprietary solutions, alongside consulting and practical services covering clinical trials, regulatory compliance, and patient safety. Its specific offerings in this area include clinical research, development of generic drugs, data analytics, regulatory affairs management, and pharmacovigilance. Beyond this, TAKE Solutions also offers IT infrastructure and support, comprehensive supply chain management, engineering, design, and sourcing services. The company caters to a diverse client base, encompassing both major and smaller innovative biopharmaceutical and medical device firms, as well as generic drug producers. Established in 2000, its main office is located in Chennai, India. TAKE Solutions Limited functions as a subsidiary of TAKE Solutions Pte. Limited.
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Syngene International Ltd.
―
OneSource Specialty Pharma Limited
―